iHuman (IH)
NYSE:IH
Want to see IH full AI Analyst Report?
IH Stock Chart & Stats
$2.00
-$0.07(-4.34%)
At close: 4:00 PM EST
$2.00
-$0.07(-4.34%)
Day’s Range― - ―
52-Week Range$1.33 - $3.60
Previous CloseN/A
Volume8.51K
Average Volume (3M)17.50K
Market Cap
$70.46M
Enterprise Value-$1.04B
Total Cash (Recent Filing)$1.10B
Total Debt (Recent Filing)$12.28M
Price to Earnings (P/E)1.0
Beta0.38
Next Earnings
Jun 24, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.93%
Share Statistics
EPS (TTM)10.60
Shares Outstanding22,312,862
10 Day Avg. Volume15,971
30 Day Avg. Volume17,505
Financial Highlights & Ratios
PEG Ratio-0.51
Price to Book (P/B)0.15
Price to Sales (P/S)0.19
P/FCF Ratio3.34
Enterprise Value/Market Cap-14.80
Enterprise Value/Revenue-1.18
Enterprise Value/Gross Profit-1.74
Enterprise Value/Ebitda-8.71
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low Leverage & Strong Balance SheetiHuman’s very low debt and large equity base give it durable financial flexibility. Over 2–6 months this supports continued R&D, targeted M&A, and dividend capacity, and provides a buffer against China demographic and demand headwinds without forcing distressed funding decisions.
High Gross Margins And Sustained ProfitabilitySustained high gross margins reflect a scalable digital content model with low incremental costs. Even with revenue pressure, margin strength supports long-term product investment, profitability resilience and the ability to fund innovation and international expansion from operating earnings.
Strategic AI Acquisitions And Leadership HiresThe asset transfers and executive additions are structural: they broaden product offerings, deepen AI capabilities and target older cohorts. This diversifies the addressable market beyond preschool and strengthens competitive positioning in AI-driven learning for sustained growth.
Bears Say
Revenue Contraction In 2024–2025Two consecutive years of revenue decline reflect weaker user acquisition and lower demand tied to China's shrinking newborn cohort and softer consumer spending. Without durable new revenue streams, top-line declines constrain long-term growth prospects and increase pressure on margins.
Weakened Cash Generation And Volatile Cash ConversionOperating and free cash flow have fallen steeply, indicating weaker cash conversion and working-capital or timing stresses. This reduces internal funding for content, devices and marketing, raising reliance on the balance sheet or M&A to sustain strategic investments and dividends.
Net Margin Compression Since 2023 PeakDeclining net margins suggest rising cost pressures or weaker operating leverage as revenue falls. Persistent margin erosion would reduce reinvestable earnings and could force trade-offs between profitability, R&D spend and marketing needed to reverse user declines.
iHuman News
IH FAQ
What was iHuman’s price range in the past 12 months?
iHuman lowest stock price was $1.33 and its highest was $3.60 in the past 12 months.
What is iHuman’s market cap?
iHuman’s market cap is $70.46M.
When is iHuman’s upcoming earnings report date?
iHuman’s upcoming earnings report date is Jun 24, 2026 which is tomorrow.
How were iHuman’s earnings last quarter?
iHuman released its earnings results on Mar 31, 2026. The company reported $0.041 earnings per share for the quarter, beating the consensus estimate of N/A by $0.041.
Is iHuman overvalued?
According to Wall Street analysts iHuman’s price is currently Overvalued.
Does iHuman pay dividends?
iHuman pays a Annually dividend of $0.085 which represents an annual dividend yield of 3.93%. See more information on iHuman dividends here
What is iHuman’s EPS estimate?
iHuman’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does iHuman have?
iHuman has 22,312,862 shares outstanding.
What happened to iHuman’s price movement after its last earnings report?
iHuman reported an EPS of $0.041 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.437%.
Which hedge fund is a major shareholder of iHuman?
Currently, no hedge funds are holding shares in IH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
iHuman
Operating within the People's Republic of China, iHuman Inc. specializes in delivering educational resources aimed at fostering cognitive growth. Their offerings reach a broad audience, encompassing individual consumers, early learning institutions, and wholesale distributors. A significant portion of their portfolio consists of interactive and self-guided digital applications. These include popular titles such as iHuman Chinese, iHuman ABC, iHuman Pinyin, iHuman Magic Thinking, iHuman Books, iHuman Stories, iHuman Reading, iHumanpedia, iHuman Kids Workout, iHuman Coding, iHuman Fun Idioms, iHuman Little Artists, and iHuman Readers. Beyond digital platforms, iHuman Inc. also furnishes a diverse array of physical educational content, ranging from books and interactive tools to smart devices. These resources are specifically designed to cultivate essential childhood skills, such as verbal communication, analytical reasoning, autonomous reading, and creative expression. Established in 1996, the company maintains its headquarters in Beijing, located within the People's Republic of China.
Technical Analysis
China Online Education Group
―
Sunlands Online Education Group
―
Skillsoft
―
Classover Holdings
―
Genius Group Limited
―
Ownership Overview
―
Insiders
―
Mutual Funds
0.09% Other Institutional Investors
99.91% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---